Can exhaled NO fraction predict radiotherapy-induced lung toxicity in lung cancer patients?

Radiation Oncology

Anne Charloux²  Elisabeth Quoix⁵  Bernard Geny⁵  Catherine Schumacher¹  Emile Urban-Kraemer⁵  Monique Oswald-Mammosser⁵  Nicolas Meyer³  M-Young Jeung⁴  Georges Noel¹  Irina Enache⁵ 

[1] Département Universitaire de Radiothérapie, Centre de lutte contre le cancer Paul Strauss, 3, rue de la Porte de l’Hôpital, BP 42, 67065, Strasbourg, France;Service de Physiologie et d’Explorations Fonctionnelles, Pôle de Pathologie Thoracique, Hôpitaux Universitaires, BP 426, 67091, Strasbourg Cedex, France;Laboratoire de Biostatistique, Université de Strasbourg, Faculté de Médecine, 4, rue Kirschleger, 67085, Strasbourg, France;Service de Radiologie B, Hôpitaux Universitaires, BP 426, 67091, Strasbourg Cedex, France;Pôle de Pathologie Thoracique, Hôpitaux Universitaires, BP 426, 67091, Strasbourg Cedex, France

关键词: Lung cancer;    Exhaled nitric oxide;    Radiation pneumonitis;    Radiotherapy;    Chemotherapy;   

Others  :  1228579
DOI  :  10.1186/1748-717X-7-117

 received in 2012-02-03, accepted in 2012-07-17,  发布年份 2012

【 摘 要 】

Background

A large increase in nitric oxide fraction (FeNO) after radiotherapy (RT) for lung cancer may predict RT-induced lung toxicity.

Methods

In this study, we assessed the relationships between FeNO variations and respiratory symptoms, CT scan changes or dose volume histogram (DVH) parameters after RT. We measured FeNO before RT, 4, 5, 6, 10 weeks, 4 and 7.5 months after RT in 65 lung cancer patients.

Results

Eleven lung cancer patients (17%) complained of significant respiratory symptoms and 21 (31%) had radiation pneumonitis images in >1/3 of the irradiated lung after RT. Thirteen patients (20%) showed increases in FeNO >10 ppb. The sensitivity and specificity of a >10 ppb FeNO increase for the diagnosis of RT-associated respiratory symptoms were 18% and 83%, respectively. There was no correlation between DVH parameters or CT scan changes after RT and FeNO variations. Three patients (5%) showed intriguingly strong (2 or 3-fold, up to 55 ppb) and sustained increases in FeNO at 4 and 5 weeks, followed by significant respiratory symptoms and/or radiation-pneumonitis images.

Conclusion

Serial FeNO measurements during RT had a low ability to identify lung cancer patients who developed symptoms or images of radiation pneumonitis. However, three patients presented with a particular pattern which deserves to be investigated.

【 授权许可】

   
2012 Enache et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1 .

Figure 2 .

Figure 3 .

Figure 4 .

【 参考文献 】

• [1]Dweik RA, Boggs PB, Erzurum SC, Irvin CG, Leigh MW, Lundberg JO, Olin AC, Plummer AL, Taylor DR: An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications. American journal of respiratory and critical care medicine 2011, 184:602-615.
• [2]Dummer JF, Epton MJ, Cowan JO, Cook JM, Condliffe R, Landhuis CE, Smith AD, Taylor DR: Predicting corticosteroid response in chronic obstructive pulmonary disease using exhaled nitric oxide. American journal of respiratory and critical care medicine 2009, 180:846-852.
• [3]Tiev KP, Hua-Huy T, Kettaneh A, Allanore Y, Le-Dong NN, Duong-Quy S, Cabane J, Dinh-Xuan AT: Alveolar concentration of nitric oxide predicts pulmonary function deterioration in scleroderma. Thorax Epub 2011. Oct 24
• [4]Chan HP, Lewis C, Thomas PS: Exhaled breath analysis: novel approach for early detection of lung cancer. Lung cancer (Amsterdam, Netherlands) 2009, 63:164-168.
• [5]Horvath I, Lazar Z, Gyulai N, Kollai M, Losonczy G: Exhaled biomarkers in lung cancer. Eur Respir J 2009, 34:261-275.
• [6]Guida G, Culla B, Scirelli T, Bellone G, Sciascia S, Brussino L, Novero D, Palestro G, Heffler E, Gavarotti P, Rolla G, Bucca C: Exhaled nitric oxide and nitric oxide synthase expression in Hodgkin’s disease. International journal of immunopathology and pharmacology 2009, 22:1027-1034.
• [7]Holmkvist T, Erlanson M, Merilainen P, Hogman M: Exhaled nitric oxide is highly increased in a case of Hodgkin’s disease. Acta oncologica (Stockholm, Sweden) 2003, 42:788-789.
• [8]Liu CY, Wang CH, Chen TC, Lin HC, Yu CT, Kuo HP: Increased level of exhaled nitric oxide and up-regulation of inducible nitric oxide synthase in patients with primary lung cancer. British journal of cancer 1998, 78:534-541.
• [9]Masri FA, Comhair SA, Koeck T, Xu W, Janocha A, Ghosh S, Dweik RA, Golish J, Kinter M, Stuehr DJ, Erzurum SC, Aulak KS: Abnormalities in nitric oxide and its derivatives in lung cancer. American journal of respiratory and critical care medicine 2005, 172:597-605.
• [10]Wewel AR, Crusius JA, Gatzemeier U, Heckmayr M, Becher G, Magnussen H, Jorres RA, Holz O: Time course of exhaled hydrogen peroxide and nitric oxide during chemotherapy. Eur Respir J 2006, 27:1033-1039.
• [11]Koizumi M, Yamazaki H, Toyokawa K, Yoshioka Y, Suzuki G, Ito M, Shinkawa K, Nishino K, Watanabe Y, Inoue T, Ozeki S, Matsumura S, Inoue T: Influence of thoracic radiotherapy on exhaled nitric oxide levels in patients with lung cancer. Japanese journal of clinical oncology 2001, 31:142-146.
• [12]Dehing-Oberije C, De Ruysscher D, van Baardwijk A, Yu S, Rao B, Lambin P: The importance of patient characteristics for the prediction of radiation-induced lung toxicity. Radiother Oncol 2009, 91:421-426.
• [13]Fleckenstein K, Gauter-Fleckenstein B, Jackson IL, Rabbani Z, Anscher M, Vujaskovic Z: Using biological markers to predict risk of radiation injury. Seminars in radiation oncology 2007, 17:89-98.
• [14]Guerrero T, Martinez J, McCurdy MR, Wolski M, McAleer MF: Elevation in Exhaled Nitric Oxide Predicts for Radiation Pneumonitis. International journal of radiation oncology, biology, physics 2012, 82:981-8.
• [15]McCurdy MR, Wazni MW, Martinez J, McAleer MF, Guerrero T: Exhaled nitric oxide predicts radiation pneumonitis in esophageal and lung cancer patients receiving thoracic radiation. Radiother Oncol 2011, 101:443-448.
• [16]I.C.R.U. report 62: Prescribing, recording and reporting photon beam therapy (supplement to ICRU report 50). International Commission on Radiation Units&Measurements, Bethesda, MD; 1999.
• [17]Goddard PR, Nicholson EM, Laszlo G, Watt I: Computed tomography in pulmonary emphysema. Clinical radiology 1982, 33:379-387.
• [18]Bankier AA, De Maertelaer V, Keyzer C, Gevenois PA: Pulmonary emphysema: subjective visual grading versus objective quantification with macroscopic morphometry and thin-section CT densitometry. Radiology 1999, 211:851-858.
• [19]ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005 American journal of respiratory and critical care medicine 2005, 171:912-930.
• [20]Tsoukias NM, George SC: A two-compartment model of pulmonary nitric oxide exchange dynamics. J Appl Physiol 1998, 85:653-666.
• [21]Kharitonov SA, Gonio F, Kelly C, Meah S, Barnes PJ: Reproducibility of exhaled nitric oxide measurements in healthy and asthmatic adults and children. Eur Respir J 2003, 21:433-438.
• [22]Mocellin S, Bronte V, Nitti D: Nitric oxide, a double edged sword in cancer biology: searching for therapeutic opportunities. Medicinal research reviews 2007, 27:317-352.
• [23]Nozaki Y, Hasegawa Y, Takeuchi A, Fan ZH, Isobe KI, Nakashima I, Shimokata K: Nitric oxide as an inflammatory mediator of radiation pneumonitis in rats. The American journal of physiology 1997, 272:L651-658.
• [24]De Ruysscher D, Dehing C, Yu S, Wanders R, Ollers M, Dingemans AM, Bootsma G, Hochstenbag M, Geraedts W, Pitz C, Simons J, Boersma L, Borger J, Dekker A, Lambin P: Dyspnea evolution after high-dose radiotherapy in patients with non-small cell lung cancer. Radiother Oncol 2009, 91:353-359.
• [25]Morgan GW, Breit SN: Radiation and the lung: a reevaluation of the mechanisms mediating pulmonary injury. International journal of radiation oncology, biology, physics 1995, 31:361-369.